Annual Drug Patent Expirations for AMITIZA
Amitiza is a drug marketed by Sucampo Pharma Llc and is included in one NDA. It is available from two suppliers. There are sixteen patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for AMITIZA.
This drug has two hundred patent family members in twenty-eight countries.
The generic ingredient in AMITIZA is lubiprostone. Two suppliers are listed for this compound. Additional details are available on the lubiprostone profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
